» Articles » PMID: 625068

Flow Microfluorometric Analysis of P388 Murine Leukemia After Administration of Vincristine and Maytansine in Vivo

Overview
Specialty Oncology
Date 1978 Mar 1
PMID 625068
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Maytansine is a new drug undergoing clinical investigation. It has functional similarities to vincristine. Maytansine and vincristine were given to CDF1 mice with P388 leukemic ascites, and the cytokinetic response of the tumor cells was analyzed with a flow microfluorometer; mithramycin was used as the DNA fluorochrome. The results indicated a similar series of cytokinetic effects after administration of both drugs, though these effects were greater and more persistent after maytansine was given. Although both drugs produced some degree of multinucleation and endoreduplication, vincristine produced a discrete population of cells with a DNA content (fluorescence) equivalent to octoploidy (8C). Microscopy of the sorted 8C cells at 24 hours indicated 54% multinucleation and 33% mitotic figures. Most cells remained blocked in the G1-phase for at least 96 hours after administration of both drugs, which indicated that rapid DNA content distributions can be used to determine not only the effects of drugs on cell cycle distribution but also the duration of drug action.

Citing Articles

Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy.

Westhoff M, Schuler-Ortoli M, Zerrinius D, Hadzalic A, Schuster A, Strobel H Pharmaceuticals (Basel). 2022; 15(1).

PMID: 35056150 PMC: 8779796. DOI: 10.3390/ph15010091.


Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.

Barok M, Tanner M, Koninki K, Isola J Breast Cancer Res. 2011; 13(2):R46.

PMID: 21510863 PMC: 3219209. DOI: 10.1186/bcr2868.


Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules.

Grdina D, White R, Stragand J Br J Cancer. 1983; 48(2):279-87.

PMID: 6882666 PMC: 2011441. DOI: 10.1038/bjc.1983.183.


Studies on the so-called "synchronization therapy" of tumors with vincristine.

Schultze B, Jellinghaus W, Basler U, Dettmer J, Maurer W J Cancer Res Clin Oncol. 1983; 105(3):266-74.

PMID: 6853589 DOI: 10.1007/BF00395756.


The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.

McGown A, Poppitt D, Swindell R, Fox B Cancer Chemother Pharmacol. 1984; 13(1):47-53.

PMID: 6733842 DOI: 10.1007/BF00401447.